Highlights Alvotech Nyse

Equities

ALVO

LU2458332611

Market Closed - Nyse Other stock markets 21:00:00 16/05/2024 BST			5-day change	1st Jan Change
13.5 ^USD	+1.12%		-1.40%	+43.92%

04-30	Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals	MT
04-30	Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals	04-30	MT
Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent	04-30	MT
Alvotech Announces U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira	04-30	CI
Cigna to offer Humira rivals with $0 copay at specialty pharmacy	04-25	RE
Alvotech Announces Topline Results from A Confirmatory Clinical Study for AVT05, A Proposed Biosimilar for Simponi	04-24	CI
Sector Update: Health Care Stocks Advance Late Afternoon	04-19	MT
Sector Update: Health Care Stocks Rise Friday Afternoon	04-19	MT
Sector Update: Health Care	04-19	MT
Alvotech Shares Rise After Signing Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US	04-19	MT
Alvotech Signs Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US	04-19	MT
Alvotech Signs U.S. Agreement to Expand Access for Newly Approved High-Concentration Interchangeable Biosimilar to Humira®	04-19	CI
Alvotech and Teva Announces U.S. FDA Approval of SELARSDI (ustekinumab-aekn), biosimilar to Stelara (ustekinumab)	04-17	CI
Alvotech, Teva Get FDA Approval for Stelara Biosimilar Psoriasis Treatment	04-16	DJ
J&J beats first-quarter profit estimates on cancer drugs strength	04-16	RE
Alvotech Provides Earnings Guidance for the Year 2024 and 2025	03-21	CI
Alvotech Full-Year 2023 Loss Narrows, Revenue Rises	03-20	MT
Alvotech Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
Global markets live: Domino's Pizza, Walt Disney, Broadcom, Ryanair, Exxon Mobil, Goldman Sachs...	02-26
How long will this bullish phase last?	02-26
Alvotech Shares Rise Premarket After Humira Biosimilar Approval	02-26	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Alvotech Nyse

Equities

ALVO

LU2458332611

Highlights

Filters